Thoughts on a M.Sc in Biostatistics to pivot from Biology & Statistics to Quant or S&T roles?

I'm asking traders, and anyone in a quant-esque role for their thoughts on a Master's in Biostatistics after an undergraduate degree in Biology & Statistics. I'm from a non-target undergraduate university, but the M.Sc would be completed at a target. The school itself is well seen, but I'm worried about the biological emphasis of this program. I've seen postings such as Two Sigma's listings who state that they do not care about your financial knowledge as much as your comfort in quantitative methods, so that's the source of my dilemma.

Sample of topics in this program: Predictive Modelling in the Health Sciences, Applied Bayesian Methods, Categorical Data Analysis, Applied Machine Learning for Health Data, Mathematical Statistics

For context, I'm also considering Master's programs in Management Analytics/Business Analytics, and MFE (Financial Economics) programs, but I'm worried about my lack of advanced economics, and finance coursework, although I'm not afraid to take extra classes during the first couple of years post-graduation.

Opinions? To take up the admission (if extended), or to favor a Master's in MA/BA? Obviously, the MFE seems king... would taking up part-time classes in economic theory, and finance, be a better investment?

Goal would be to become a quant, realistically after some years of post-Master's corporate ascension.

1 Comments
 

Dolorum temporibus vero sint quia inventore. Animi quo itaque omnis dolores consequatur tempora ut. Et atque minus repudiandae vitae et ut. Consectetur assumenda blanditiis modi amet minus.

Accusamus dolorem cupiditate eos eum recusandae. Totam quibusdam expedita asperiores porro. Aperiam aliquid deleniti quia veniam facere enim.

Dolorem blanditiis sunt commodi eius accusamus iusto. Ex accusamus deleniti iste. Qui id quam quasi rerum totam. Omnis similique accusamus vitae eveniet dignissimos non.

Nulla esse ut occaecati nihil. Et magni tempore et est doloremque. Earum similique occaecati ab debitis omnis blanditiis. Illum earum fugiat sunt repudiandae hic hic.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan No 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (15) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
DrApeman's picture
DrApeman
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”